Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 4/20 | 0.46 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.41 |
| ▸ | TDO2 | P48775 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 3/20 | 0.35 |
| ▸ | IDO1 | P14902 | 2/20 | 0.35 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.35 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.34 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.34 |
| ▸ | AR | P10275 | 1/20 | 0.34 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | METAP2 | P50579 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11577937 | 0.81 | METAP2 (0.39) | NOS1ADORA2ALRRK2FGFR1FGFR2 | |
| SCHEMBL204492 | 0.79 | NOS1 (0.53) | NOS1DYRK1ATDO2ADORA2AFGFR1 | |
| SCHEMBL3515094 | 0.76 | MAPT (0.46) | NOS1ADORA2ALRRK2FGFR1FGFR2 | |
| SCHEMBL19204828 | 0.76 | LRRK2 (0.40) | NOS1ADORA2AIDO1LRRK2FGFR1 | |
| SCHEMBL202508 | 0.76 | NOS1 (0.46) | NOS1DYRK1ATDO2IDO1FGFR1 | |
| SCHEMBL766959 | 0.76 | NOS1 (0.46) | NOS1DYRK1ATDO2ADORA2AIDO1 | |
| SCHEMBL2430496 | 0.76 | NOS1 (0.50) | NOS1DYRK1ATDO2MAOBIDO1 | |
| SCHEMBL18107535 | 0.76 | FGFR1 (0.44) | NOS1ADORA2AIDO1LRRK2FGFR1 | |
| SCHEMBL20112865 | 0.76 | NOS1 (0.46) | NOS1ADORA2AIDO1LRRK2FGFR1 | |
| SCHEMBL7571990 | 0.76 | NOS1 (0.46) | NOS1DYRK1ATDO2ADORA2ALRRK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017133667-A1 | PYRIMIDINE AND PYRIDINE DERIVATIVES AND USE IN TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA THEREOF | SAVIRA PHARMACEUTICALS GMBH (AT) | 2017-08-10 | — | — | WO | disclosed |
| WO-2017133670-A1 | PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA | SAVIRA PHARMACEUTICALS GMBH (AT) | 2017-08-10 | — | — | WO | disclosed |
| US-9168317-B2 | In vivo imaging method of mood disorders | GE HEALTHCARE LIMITED (GB) | 2015-10-27 | — | — | US | disclosed |